manufacturer savings programs may be available for eligible patients
There is, however, some concern that GLP-1 RAs may affect the absorption of immunosuppressive drugs owing to their role in slowing gastric emptying.4,5 To date, data on tacrolimus doses and levels have been published on a small number of KT recipients treated with GLP-1 RAs.6,811 In our study, with a significant number of subjects, trough levels, doses and tacrolimus C/D ratio did not change significantly during follow-up, allowing confidence regarding the safety of immunosuppressive treatment
Sobo or their prescribing clinician when side effects are persistent, worsening, confusing, or interfering with nutrition, hydration, bowel function, energy, sleep, or daily life
Early Days of a Revolution: How GLP-1s are Already Changing Consumer Spending. Coleman, J